EUVIMED · CrossrefZeitschrift
European Journal of Heart Failure
ISSN 1388-9842 · Oxford University Press (OUP)
Neueste Artikel
Bioelectrical impedance analysis and treatment response to dapagliflozin, spironolactone and their combination: a SOGALDI-PEF analysis
Evaluating the role of lower extremity elastic bandage in patients with acute decompensated heart failure
The lymphatic system: the new target for effective decongestion in decompensated heart failure?
Ventricular arrhythmia–heart failure interaction and mortality in ICD recipients after myocardial infarction
Efficacy of empagliflozin in heart failure with preserved ejection fraction according to the presence of echocardiographic features of diastolic dysfunction in the EMPEROR-Preserved trial
Correction to: The effect of vericiguat on sudden cardiac death: insights from the VICTOR trial
Dipeptidyl peptidase 3-positive circulatory shock: from targetable intensive care unit endotype to Horizon Europe precision-therapy trial
Performance of prediction models for incident heart failure and heart failure hospitalization in individuals with type 2 diabetes: a systematic review and meta-analysis
Rethinking tricuspid regurgitation in heart failure—a pathophysiology-based holistic approach for individualized patient management
Sex differences in heart failure treatment: a signal worth pursuing?
Sex-based differences in chronic heart failure: a systematic review and meta-analysis of randomized controlled trials
Baseline characteristics and utilization of medical therapies in acute hospitalized and chronic heart failure patients enrolled in GRASP-HF: differences between ICARe-HF and Non-ICARe-HF centres
Longitudinal proteomic organ-specific ageing in heart failure
The effect of vericiguat on sudden cardiac death: insights from the VICTOR trial
Genitourinary tract infections and SGLT2 inhibitors in heart failure: an EMPEROR-Pooled analysis
Very high-dose loop diuretics for worsening heart failure—a randomized pilot trial
Genitourinary tract infections in SGLT2 inhibitors treated heart failure patients
Impact of dapagliflozin, spironolactone, and their combination on markers of kidney function and injury: an analysis from SOGALDI-PEF
The global epidemiology of heart failure: a comprehensive and contemporary review
Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials
Exploration of arrhythmia burden in cardiac amyloidosis using implantable loop recorders (the EXACLIBUR trial)
Predictors of metabolic heart failure with preserved ejection fraction in patients with nonalcoholic fatty liver disease
Development of a digital tool focused on self-care for patients with heart failure in a tertiary hospital
Early effects of SGLT2 inhibitors in acute heart failure: an individual patient-level meta-analysis
Acute myocardial infarction vs acute decompensated heart failure in cardiogenic shock: a systematic review and meta-analysis of clinical phenotypes and mortality
Changes in upright haemodynamics preceding heart failure events and other hospitalizations
Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomized clinical trial
EJHF expert consensus statement on the diagnosis and management of hypertrophic cardiomyopathy
Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trial
Iron deficiency definitions and their clinical and prognostic associations across the spectrum of left ventricular ejection fraction in heart failure
EUVIMED